| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.69B | -4.3% |
| R&D Expense | $150.0M | -5.7% |
| SG&A Expense | $1.76B | -9.5% |
| Operating Income | $2.03B | -3.6% |
| Interest Expense | $140.0M | +2.9% |
| Pre-tax Income | $1.89B | -3.7% |
| Income Tax | $519.0M | -4.1% |
| Net Income | $1.25B | +0.6% |
| EPS (Basic) | $2.98 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.19B | -24.0% |
| Accounts Receivable | $3.36B | +3.9% |
| Inventory | $617.0M | -0.8% |
| Current Assets | $6.14B | -25.6% |
| Total Assets | $9.82B | -20.0% |
| Current Liabilities | $6.84B | +9.5% |
| Long-term Debt | $6.63B | -8.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.56B | -10.9% |
| Investing Cash Flow | -$33.0M | +62.9% |
| Financing Cash Flow | -$3.65B | -6396.6% |
| +2.4% |
| EPS (Diluted) | $2.96 | +2.4% |
| Total Liabilities |
| $14.48B |
| -5.1% |
| Stockholders' Equity | -$4.87B | -34.3% |